Home > News > Researchers may find hope for a successful HIV drug in gold
June 13th, 2008
Researchers may find hope for a successful HIV drug in gold
Abstract:
An HIV drug dismissed for its side effects will get a second chance to prove its value, thanks in part to research, which Christian Melander and T. Eric Ballard conducted.
Melander, an assistant professor of chemistry, and Ballard, a graduate student studying synthetic and organic chemistry, worked with UNC-Chapel Hill's microbiology department and the University of Colorado at Boulder's chemistry departments to develop a new nanoparticle called SDC-1721.
Adapted from a particle known as TAK-779, SDC-1721 has been shown to bind with HIV particles and prevent them from fusing with healthy cells. Unlike TAK-779, SDC-1721 does not contain an ammonium salt found to cause inflammation at the site of injection.
"To synthesize SDC-1721, it was much easier to take out the ammonium salt then to try to retain it," Ballard said. "It was a risk, since that was an active part of the molecule, but for ease of synthesis, it was deemed necessary."
Source:
technicianonline.com
Bookmark:
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Discoveries
Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||